Skip to content
RecallWatchMedical Device Safety
Class IOngoingZ-1566-2026

Erbe USA Inc recalls Flexible Cryoprobe (OD 1.1mm

Erbe USA IncMarietta, GA, United StatesReported Apr 1, 2026 · 5 months ago
Legal News Analyst ·

Reason for recall

Probes may rupture/burst during activation

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • Flexible Cryoprobe (OD 1.1mm, L1.15mm) w/ oversheath (OD2.6mm, L817mm) REF: 20402-401 STERILE EO. For surgical useUDI
    UDI 04050147021785/
    400 affected lots
    WO471345WO471346WO471347WO471348WO471349WO472537WO472538WO472539
    +392 moreWO472540WO472594WO472595WO472596WO472597WO472598WO472599WO472600WO472601WO472602WO472603WO472617WO472618WO472619WO472620WO472621WO472622WO472623WO472624WO472625WO472626WO472627WO472628WO472629WO472630WO472631WO472632WO472633WO472634WO472635WO472636WO472642WO472643WO472644WO472647WO472648WO472649WO473613WO473614WO473615WO473616WO473617WO473618WO473619WO473646WO473647WO473648WO473649WO473650WO473651WO474289WO474290WO474291WO474292WO474580WO474581WO474582WO474583WO474584WO474585WO474586WO474587WO474588WO475359WO475360WO475361WO475362WO475363WO475364WO475368WO475369WO475370WO475371WO475372WO475373WO475374WO475375WO475376WO475377WO475378WO475382WO475383WO475384WO475385WO475386WO476017WO476018WO476019WO476020WO476021WO476226WO476227WO476228WO476229WO476230WO476231WO476232WO476233WO476234WO476235WO476273WO476274WO476275WO476690WO476691WO476692WO476693WO476694WO476695WO476696WO476697WO476698WO477070WO477071WO477072WO477073WO477497WO477498WO477499WO477500WO477501WO477502WO477503WO477504WO477505WO477506WO477507WO477508WO477686WO477687WO477688WO477689WO477979WO477980WO477981WO477982WO477983WO477984WO477985WO477986WO477987WO477988WO477989WO477990WO478178WO478179WO478180WO478181WO478182WO478183WO478184WO478185WO478186WO478187WO478188WO478952WO478953WO478954WO478955WO478957WO461310WO461311WO461312WO461314WO461315WO461829WO461831WO461832WO461833WO461834WO461835WO461842WO461843WO461844WO461847WO461848WO462117WO462118WO462119WO462120WO462121WO462122WO462123WO462124WO462125WO462128WO462129WO462130WO462373WO462374WO462375WO462376WO462377WO462378WO462379WO462380WO462387WO462388WO462389WO462397WO462825WO462826WO462827WO462828WO462829WO462830WO462831WO462838WO462839WO462840WO462841WO462842WO462843WO462844WO462845WO462846WO462847WO462848WO462849WO463308WO463309WO463310WO463311WO463312WO463313WO463314WO463316WO463317WO463390WO463391WO463392WO463393WO463394WO463395WO463396WO463397WO463398WO463399WO463400WO463401WO463402WO463403WO463404WO463405WO463406WO463407WO463408WO463409WO464270WO464271WO464272WO464273WO464274WO464275WO464276WO464277WO464278WO464279WO464699WO464700WO464701WO464702WO464703WO464994WO464995WO464996WO464997WO465021WO465022WO465023WO465024WO465025WO465026WO465027WO465050WO465051WO465052WO465053WO465054WO465055WO465056WO465057WO465066WO465067WO465068WO465069WO465243WO465244WO465245WO465246WO465247WO465248WO465249WO465255WO465256WO465257WO465258WO465259WO465260WO465261WO465262WO465266WO465267WO465268WO465269WO467858WO467859WO467860WO467861WO467862WO467863WO467884WO467885WO467886WO468210WO468211WO468212WO468213WO468214WO468215WO468216WO468217WO468218WO468219WO468220WO468221WO468230WO468231WO468232WO468609WO468610WO468611WO468612WO468613WO468614WO468618WO468619WO468620WO468621WO468622WO468623WO468624WO468625WO468626WO468627WO468628WO468629WO468630WO468631WO468632WO468634WO468635WO468636WO468637WO468638WO468639WO468640WO468641WO468654WO468655WO468656WO468657WO468658WO468659WO468660WO468661WO468662WO468663WO468664WO468665WO468666WO468669WO468670WO469350WO469351WO469352WO469353WO469354WO469357WO469358WO469359WO471335WO471336WO471337WO471338WO471339WO471340WO471341WO471342WO471344W4468495W4465348

What the firm is doing

On February 12, 2026, ERBE USA issued a "Urgent: Medical Device Recall (Removal)" via E-Mail. ERBE asked consignees to take the following actions: 1. Discontinue use of the products with the affected lot numbers. 2.Examine your inventory, remove, and quarantine any identified devices with the affected lot numbers 3.Ensure all applicable personnel within the vicinity of device activation carefully read the content of this notification. If affected product has been transferred to a different location, please ensure that location and personnel receive a copy of this notification. 4.Please contact Erbe at fieldaction.us@erbegroup.com or 678-483-8499, to obtain a Return Material Authorization number 5.Please complete the Response Form and return to Erbe 6.If a response is not received within 4 weeks of this letter, Erbe will provide a second and third reminder in 4-week increments. 7.If you have further distributed this product, identify your locations, and forward this notification to them. 8.Erbe requests you to report any complaints, including any instances of ruptures/bursts, to our Technical Service Department at 770-955-4400. Adverse events experienced with the use of this product may also be reported to the FDA s MedWatch Adverse Event Reporting program.

DistributionShow details

US Nationwide distribution, including Puerto Rico.

Class IWhat this means

A reasonable probability that use of the product will cause serious adverse health consequences or death.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class I recalls

Class IOngoingZ-2879-2026

Boston Scientific Neuromodulation Corporation recalls INFINION CX LEAD KIT

Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention, i…

  • Totally Implanted For Pain Relief Spinal-Cord Stimulator
  • Device Design
Boston Scientific Neur…CAAug 12, 2026